Skip to main content

Advertisement

Table 1 HIV prevalence and incidence of women participating in trials in KwaZulu-Natal, and overall trial outcome.

From: Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa

Trial (total enrolment) Years Location of HPRU sites (no. enrolled) HIV prevalence (%) HIV incidence (/100 woman years) Overall outcome of trial: HR (95% CI)
MIRA (5045) 2003-2006 Durban (1515) 39 6.8 1.05 (0.84-1.32) P = 0.65
Carraguard (6202) 2004-2007 Durban (1485) 43 6 0.87 (0.69-1.09) P = 0.302
Cellulose sulphate (1428) 2006-2007 Durban (606) 51 5.29 1.61 (0.86-3.01) P = 0.13
HPTN 035 (3101) 2005-2008 Durban (702) Hlabisa (346) 21.6 28.2 4.6 9.1 0.71 (0.46-1.11) P = 0.1331
MDP 301 (9385) 2005-2009 Durban (2392) 36 6.1 1.05 (0.82-1.34) P = 0.712
  1. HR = Hazard ratio